Skip to Content

ibr 280 (Imbruvica 280 mg)

Generic Name: ibrutinib

Pill with imprint ibr 280 is Purple, Elliptical / Oval and has been identified as Imbruvica 280 mg. It is supplied by Pharmacyclics, Inc..

Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; non-hodgkin's lymphoma; mantle cell lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 280 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ibr 280

Imbruvica

Generic Name
ibrutinib
Imprint
ibr 280
Strength
280 mg
Color
Purple
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
BTK inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pharmacyclics, Inc.
National Drug Code (NDC)
57962-0280

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.